Gene therapy specific for ovarian cancer by IAI.3B promoter-driven oncolytic adenovirus

被引：0
|
作者：
Hamada, Katsuyuki [1 ]
机构：
[1] Ehime Univ, Matsuyama, Ehime, Japan
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3006
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A novel hTERT promoter-driven E1A therapeutic for ovarian cancer
    Xie, Xiaoming
    Hsu, Jennifer L.
    Choi, Min-Gew
    Xia, Weiya
    Yamaguchi, Hirohito
    Chen, Chun-Te
    Trinh, Bon Q.
    Lu, Zhen
    Ueno, Naoto T.
    Wolf, Judith K.
    Bast, Robert C., Jr.
    Hung, Mien-Chie
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (08) : 2375 - 2382
  • [32] A novel hTERT promoter-driven E1A therapeutic for ovarian cancer
    Xie, Xiaoming
    Hsu, Jennifer
    Choi, Min-Gew
    Xia, Weiya
    Yamaguchi, Hirohito
    Chen, Chun-Te
    Lu, Zhen
    Bast, Robert
    Hung, Mien-Chie
    CANCER RESEARCH, 2009, 69
  • [33] Tumor-specific imaging through progression elevated gene-3 promoter-driven gene expression
    Hyo-eun C Bhang
    Kathleen L Gabrielson
    John Laterra
    Paul B Fisher
    Martin G Pomper
    Nature Medicine, 2011, 17 : 123 - 129
  • [34] Multidisciplinary Cancer Therapy with Telomerase-Specific Oncolytic Adenovirus
    Fujiwara, Toshiyoshi
    Kagawa, Shunsuke
    Tazawa, Hiroshi
    CURRENT CANCER THERAPY REVIEWS, 2015, 11 (03) : 178 - 187
  • [35] Combination of bladder cancer-specific oncolytic adenovirus gene therapy with cisplatin on bladder cancer in vitro
    Wang, Li
    Zhang, Yunxin
    Zhao, Jinxia
    Xiao, Erlong
    Lu, Jianzhong
    Fu, Shengjun
    Wang, Zhiping
    TUMOR BIOLOGY, 2014, 35 (11) : 10879 - 10890
  • [36] Chemotherapeutic agents enhance the antitumor efficacy of MDR1 promoter-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity
    Shiau, A. L.
    Su, B. H.
    Shieh, G. S.
    Tseng, Y. L.
    Wu, C. L.
    HUMAN GENE THERAPY, 2016, 27 (11) : A89 - A89
  • [37] The efficacy of adenovirus-mediated gene therapy of ovarian cancer is enhanced by using the cytomegalovirus promoter
    Tong, XW
    Engehausen, DG
    Freund, CTF
    Agoulnik, I
    Guo, ZS
    Oehler, MK
    Kim, TE
    Hasenburg, A
    Contant, CF
    Woo, SLC
    Kieback, DG
    ANTICANCER RESEARCH, 1998, 18 (2A) : 719 - 725
  • [38] Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: Construction and testing of a tissue-specific adenovirus vector
    Latham, JPF
    Searle, PF
    Mautner, V
    James, ND
    CANCER RESEARCH, 2000, 60 (02) : 334 - 341
  • [39] Prostate Specific Antigen Promoter-Driven Adenovirus-Mediated Expression of Both ODC and AdoMetDC Antisenses Inhibit Prostate Cancer Growth
    Li, Wei
    Xiong, Hui
    Hong, Yi-lin
    Zhang, Chun-hua
    Liu, Chang-chun
    CHINESE JOURNAL OF CANCER RESEARCH, 2010, 22 (03) : 224 - 230
  • [40] Prostate Specific Antigen Promoter-Driven Adenovirus-Mediated Expression of Both ODC and AdoMetDC Antisenses Inhibit Prostate Cancer Growth
    Wei Li1*
    ChineseJournalofCancerResearch, 2010, 22 (03) : 224 - 230
12345